2 URSACHE, ÜBERTRAGUNG UND ENTWICKLUNG

(20) Sharma SK, Mohan A, Sharma A, Mitra DK. Miliary tuberculosis: new insights into an old
disease. Lancet Infect Dis 2005; 5(7):415-430.
(21) Tufariello JM, Chan J, Flynn JL. Latent tuberculosis: mechanisms of host and bacillus that
contribute to persistent infection. Lancet Infect Dis 2003; 3(9):578-590.
(22) Moran-Mendoza O, Marion SA, Elwood K, Patrick D, FitzGerald JM. Risk factors for
developing tuberculosis: a 12-year follow-up of contacts of tuberculosis cases. Int J Tuberc
Lung Dis 2010; 14(9): 1112-9
(23) Horsburgh CR, Jr. Priorities for the treatment of latent tuberculosis infection in the United
States. N Engl J Med 2004; 350(20):2060-2067.
(24) Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC et al. The growing
burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med
2003; 163(9):1009-1021.
(25) Kim SJ, Hong YP, Lew WJ, Yang SC, Lee EG. Incidence of pulmonary tuberculosis among
diabetics. Tubercle Lung Dis 1995; 76:529-533.
(26) Corbett EL, Churchyard GJ, Clayton T, Herselman P, Williams B, Hayes R et al. Risk factors
for pulmonary mycobacterial disease in South African gold miners. A case-control study. Am J
Respir Crit Care Med 1999; 159(1):94-99.
(27) Bothamley GH. Smoking and tuberculosis: a chance or causal association? Thorax 2005;
60(7):
527-528.
(28) Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD et al.
Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N
Engl J Med 2001; 345(15):1098-1104.
(29) Gomez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD. Treatment of rheumatoid
arthritis with tumor necrosis factor inhibitors may predispose to significant increase in
tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 2003; 48(8):2122-
2127.
(30) Erkens CG, Kamphorst M, Abubakar I, Bothamley GH, Chemtob D, Haas W, Migliori
GB, Rieder HL, Zellweger JP, Lange C. Tuberculosis contact investigation in low
prevalence countries: a European consensus. Eur Respir J 2010; 36(4): 925-49.
(31) Norregaard J, Heckscher T, Viskum K. Abacillary pulmonary tuberculosis. Tubercle 1990;
71:35-38.
(32) Bates JH. Reinfection Tuberculosis. How important is it? Am J Respir Crit Care Med 2001;
163(3): 600-601.
(33) Fine PE, Small PM. Exogenous reinfection in tuberculosis. N Engl J Med 1999; 341(16):1226-
1227.
(34) Sonnenberg P, Murray J, Glynn JR, Shearer S, Kambashi B, Godrey-Faussett P. HIV-1 and
recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African
mineworkers. Lancet 2001; 358(9294):1687-1693.
(35) Van Rie A, Warren R, Richardson M, Victor TC, Gie RP, Enarson DA et al. Exogenous
reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med 1999;
341(16):1174-1179.
MATB_2011_chap.02_étiologie_24.05.2011.docx Seite 8/10